AORT Artivion, Inc. Common Stock
$28.89
Price · Aug 18, 2026
Fundamentals as of Aug 7, 2026
52W Range
$19–$48
33% of range
Analyst Rating
BUY
14 analysts
Price Target
$42
+46% upside
P/E (TTM)
139.4
ROE
2.2%
Net Profit Margin
2.2%
About Artivion, Inc. Common Stock Company overview from Wikipedia
Artivion, Inc. is a distributor of cryogenically preserved human tissues for cardiac and vascular transplant applications and develops medical devices. Among its products are human heart valves, which are treated to remove excess cellular material and antigens, and BioGlue surgical adhesive.
Read more
Artivion, Inc. is a distributor of cryogenically preserved human tissues for cardiac and vascular transplant applications and develops medical devices. Among its products are human heart valves, which are treated to remove excess cellular material and antigens, and BioGlue surgical adhesive.
## History
Artivion was founded as CryoLife in Sarasota, Florida in 1984 by Steven Anderson and Robert McNally. Anderson acted as the company’s president and CEO from its founding. The company later moved from Sarasota to the Atlanta metropolitan area. In January 2022 the company changed its name to Artivion, Inc.
In 2000, CryoLife began offering a surgical adhesive called BioGlue used for sealing surgical lacerations under high pressure, such as in arteries.
In February 2008, the FDA gave CryoLife approval for a new kind of heart valve, made from human tissues, which was the first to remove cells from the transplant tissue as opposed to only cleaning the tissue. In giving the approval, the FDA said the new valve, called the CryoValve SynerGraft Pulmonary Valve, had less of a chance of rejection than previous valves.
In 2010, CryoLife acquired the rights to manufacture and distribute PerClot, an absorbable hemostatic powder used in surgery.
In January 2016, the company acquired On-X Life Technologies and its principal product, a mechanical heart valve called the On-X aortic valve replacement, for $130 million.
In October 2017, Artivion acquired JOTEC GmbH, a German-based developer of medical devices for aortic and peripheral vascular diseases, for €225 million. In September 2020, the company acquired Ascyrus Medical.
In 2021, the company received FDA premarket application approval of its PerClot absorbable hemostatic system, which comprised PerClot granules and a delivery system for surgical use. Baxter International agreed to buy PerClot from Artivion in 2021. In 2023, after final FDA approval of the product, the purchase was completed.
Source: Wikipedia, CC BY-SA 4.0 · View on Wikipedia ↗
AORT Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$28.89
Market Cap
$1.44B
P/E (TTM)
139.4
EPS (TTM)
$0.21
Revenue (TTM)
$441M
Div Yield
—
ROE
2.2%
Debt/Equity
0.5
52W Range
$19 – $48
AORT Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Configure
10-Year Performance Revenue, net income, margins and EPS trends
Revenue & Net Income
$441M
2016-12-31
→
2025-12-31
EPS
$0.21
2016-12-31
→
2025-12-31
Free Cash Flow
$839.0K
2016-12-31
→
2025-12-31
Margins
2.2%
2016-12-31
→
2025-12-31
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
AORT
Peer Median
P/E (TTM)
139.4
38.5
P/S (TTM)
3.3
2.5
P/B
3.2
4.8
EV / EBITDA
28.4
—
Price / FCF
1720.8
—
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
AORT
Peer Median
Gross Margin
64.4%
58.7%
Operating Margin
7.6%
—
Net Profit Margin
2.2%
-12.6%
ROA
1.2%
-11.8%
ROE
2.2%
-37.7%
ROIC
3.4%
—
Financial Health Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
AORT
Peer Median
Debt / Equity
0.5
25.5
Current Ratio
3.5
3.5
Quick Ratio
1.5
—
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Metric
5Y trend
AORT
Peer Median
Revenue YoY
13.6%
—
Revenue CAGR 3Y
12.0%
—
Revenue CAGR 5Y
11.8%
—
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
AORT
Peer Median
Dividends Yield, payout ratio, dividend history, 5Y CAGR
Dividend Yield
—
Payout Ratio
—
5Y Div CAGR
—
| Ex-date | Amount |
|---|---|
| Dec. 9, 2015 | $0.0300 |
| Sept. 9, 2015 | $0.0300 |
| June 10, 2015 | $0.0300 |
| March 11, 2015 | $0.0300 |
| Dec. 10, 2014 | $0.0300 |
| Sept. 10, 2014 | $0.0300 |
| June 11, 2014 | $0.0300 |
| March 12, 2014 | $0.0280 |
| Dec. 11, 2013 | $0.0280 |
| Sept. 11, 2013 | $0.0280 |
| June 12, 2013 | $0.0280 |
| March 12, 2013 | $0.0250 |
| Dec. 12, 2012 | $0.0250 |
| Sept. 12, 2012 | $0.0250 |
AORT Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
BUY
14 analysts
- Strong Buy 5 35.7%
- Buy 8 57.1%
- Hold 1 7.1%
- Sell 0 0.0%
- Strong Sell 0 0.0%
12-Month Price Target
8 analysts · 2026-08-18
Median
$42.00
← Below all targets
$28.89
Low
$38.00
High
$48.00
Median target
$42.00
+45.4%
Mean target
$42.15
+45.9%
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
-0.02%
| Period | EPS Actual | EPS Est | Surprise |
|---|---|---|---|
| June 30, 2026 | $-0.28 | $0.01 | -0.29% |
| March 31, 2026 | $0.03 | $0.05 | -0.02% |
| Dec. 31, 2025 | $0.05 | $0.08 | -0.03% |
| Sept. 30, 2025 | $0.06 | $0.02 | 0.04% |
| June 30, 2025 | $0.08 | $-0.00 | 0.08% |
| March 31, 2025 | $-0.01 | $-0.12 | 0.11% |
Peer comparison (GICS sub-industry) Key metrics vs sector peers
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| AORT | $2.25B | 217.2 | 13.6% | 2.2% | 2.2% | 64.4% |
| TNDM | $1.50B | -7.2 | 7.9% | -20.2% | -141.9% | 53.8% |
| CNMD | $1.27B | 26.9 | 5.2% | 3.4% | 4.6% | 54.6% |
| ATEC | $3.16B | -21.9 | 24.9% | -18.8% | -792.1% | 69.6% |
| ENOV | $1.52B | -1.3 | 6.7% | -52.7% | -58.5% | 59.8% |
| IART | — | -1.8 | 1.5% | -31.6% | -49.6% | — |
| KMTS | $1.21B | -8.5 | 59.0% | -138.4% | -62.1% | 51.4% |
| PRCT | $1.77B | -18.3 | 37.2% | -31.0% | -25.4% | 63.7% |
| IRMD | $1.24B | 55.6 | 14.4% | 26.8% | 23.8% | 76.8% |
| ABT | $250.18B | 33.7 | 5.7% | 14.7% | 13.1% | — |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement 18
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $441M | $389M | $354M | $314M | $299M | $253M | $276M | $263M | $190M | $180M | $146M | $145M | |
| Cost of Revenue | $157M | $140M | $125M | $111M | $101M | $85M | $93M | $90M | $61M | $61M | $55M | $53M | |
| Gross Profit | $284M | $249M | $229M | $203M | $198M | $168M | $183M | $173M | $129M | $119M | $91M | $91M | |
| R&D Expense | $31M | $28M | $29M | $39M | $36M | $24M | $23M | $23M | $19M | $13M | $10M | $9M | |
| SG&A Expense | $226M | $181M | $209M | $157M | $170M | $141M | $143M | $141M | $101M | $92M | $75M | $74M | |
| Operating Expenses | $257M | $210M | $238M | $196M | $205M | $165M | $166M | $164M | $121M | $105M | $85M | $82M | |
| Operating Income | $34M | $39M | $6M | $6M | $8M | $2M | $17M | $9M | $8M | $22M | $5M | $9M | |
| Interest Expense | · | · | $25M | $18M | $17M | $17M | $15M | $16M | $5M | $3M | $62.0K | $175.0K | |
| Interest Income | $763.0K | $1M | $1M | $147.0K | $79.0K | $217.0K | $738.0K | $226.0K | $212.0K | $72.0K | $45.0K | $50.0K | |
| Other Non-op | $10M | $-10M | $-3M | $-3M | $-6M | $-3M | $-1M | $-141.0K | $260.0K | $-437.0K | $-484.0K | $-540.0K | |
| Pretax Income | $15M | $-8M | $-22M | $-15M | $-15M | $-17M | $2M | $-6M | $4M | $18M | $6M | $9M | |
| Income Tax | $5M | $6M | $9M | $4M | $7.0K | $-492.0K | $-76.0K | $-4M | $-143.0K | $8M | $2M | $1M | |
| Net Income | $10M | $-13M | $-31M | $-19M | $-15M | $-17M | $2M | $-3M | $4M | $11M | $4M | $7M | |
| EPS (Basic) | $0.22 | $-0.32 | $-0.75 | $-0.48 | $-0.38 | $-0.44 | $0.05 | $-0.08 | $0.11 | $0.33 | $0.14 | $0.26 | |
| EPS (Diluted) | $0.21 | $-0.32 | $-0.75 | $-0.48 | $-0.38 | $-0.44 | $0.05 | $-0.08 | $0.11 | $0.32 | $0.14 | $0.25 | |
| Shares (Basic) | 45,335,000 | 41,676,000 | 40,743,000 | 40,032,000 | 38,983,000 | 37,861,000 | 37,118,000 | 36,412,000 | 33,008,000 | 31,855,000 | 27,744,000 | 27,379,000 | |
| Shares (Diluted) | 47,162,000 | 41,676,000 | 40,743,000 | 40,032,000 | 38,983,000 | 37,861,000 | 37,860,000 | 36,412,000 | 34,163,000 | 32,822,000 | 28,542,000 | 28,313,000 | |
| EBITDA | $56M | $63M | $29M | $29M | $32M | $23M | $35M | $27M | $18M | $30M | · | $15M |
Balance Sheet 28
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $65M | $53M | $59M | $39M | $55M | $61M | $34M | $41M | $40M | $57M | $38M | $33M | |
| Receivables | $90M | $79M | $72M | $62M | $53M | $46M | $53M | $47M | $48M | $28M | $23M | $21M | |
| Inventory | $92M | $80M | $82M | $74M | $77M | $73M | $53M | $45M | $47M | $26M | $15M | $13M | |
| Prepaid Expense | $43M | $19M | $16M | $18M | $15M | $14M | $12M | $7M | $5M | $3M | $5M | $5M | |
| Current Assets | $358M | $290M | $281M | $247M | $248M | $235M | $187M | $179M | $179M | $147M | $110M | $106M | |
| PP&E (Net) | $65M | $36M | $38M | $39M | $38M | $33M | $32M | $31M | $34M | $19M | $11M | $12M | |
| PP&E (Gross) | · | · | · | $127M | $120M | $111M | $103M | $96M | $93M | $74M | $64M | $62M | |
| Accum. Depreciation | · | · | · | $88M | $82M | $78M | $71M | $65M | $60M | $55M | $53M | $50M | |
| Goodwill | $254M | $241M | $247M | $244M | $250M | $260M | $187M | $189M | $188M | $78M | $11M | $11M | |
| Intangibles | $124M | $128M | $143M | $151M | $167M | $186M | $115M | $118M | $130M | $1M | $1M | $2M | |
| Other Non-current Assets | $15M | $24M | $9M | $7M | $8M | $15M | $14M | $8M | $7M | $2M | $6M | $5M | |
| Total Assets | $885M | $789M | $792M | $763M | $793M | $789M | $606M | $571M | $590M | $316M | $181M | $176M | |
| Accounts Payable | $16M | $18M | $13M | $12M | $10M | $10M | $10M | $8M | $10M | $6M | $5M | $4M | |
| Accrued Liabilities | $16M | $12M | $10M | $12M | $8M | $7M | $7M | $7M | $12M | $5M | $3M | $3M | |
| Current Liabilities | $102M | $67M | $58M | $50M | $45M | $60M | $45M | $35M | $43M | $30M | $20M | $21M | |
| Capital Leases | $34M | $40M | $44M | $41M | $45M | $14M | $18M | $0 | $7M | $11.0K | · | · | |
| Deferred Tax | $24M | $20M | $22M | $24M | $29M | $35M | $26M | $27M | $30M | $7.0K | · | · | |
| Other Non-current Liabilities | $9M | $8M | $7M | $7M | $6M | $7M | $7M | $7M | $8M | $5M | $3M | $3M | |
| Total Liabilities | $437M | $513M | $511M | $478M | $492M | $461M | $320M | $296M | $313M | $107M | $26M | $27M | |
| Long-term Debt | $215M | $314M | $307M | $308M | $309M | $292M | $216M | $217M | $219M | $72M | · | · | |
| Total Debt | $215M | $314M | $307M | $308M | $309M | $292M | $216M | $217M | $219M | $72M | · | · | |
| Common Stock | $493.0K | $434.0K | $426.0K | $418.0K | $414.0K | $404.0K | $390.0K | $385.0K | $376.0K | $342.0K | $298.0K | $292.0K | |
| Retained Earnings | $-51M | $-61M | $-48M | $-17M | $2M | $20M | $37M | $35M | $38M | $34M | $23M | $23M | |
| Treasury Stock | $15M | $15M | $15M | $15M | $15M | $15M | $15M | $15M | $13M | $12M | $11M | $9M | |
| AOCI | $-3M | $-25M | $-12M | $-22M | $-10M | $7M | $-9M | $-6M | $2M | $-429.0K | $-76.0K | $-121.0K | |
| Stockholders' Equity | $448M | $276M | $282M | $284M | $301M | $329M | $286M | $275M | $277M | $209M | $155M | $149M | |
| Liabilities + Equity | $885M | $789M | $792M | $763M | $793M | $789M | $606M | $571M | $590M | $316M | $181M | $176M | |
| Shares Outstanding | 49,330,000 | 43,432,000 | 42,569,000 | 41,830,000 | 41,397,000 | 40,394,000 | 39,018,000 | 38,463,000 | 37,618,000 | 34,230,000 | 29,766,000 | 29,229,000 |
Cash Flow 19
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $22M | $24M | $23M | $22M | $24M | $21M | $18M | $18M | $10M | $8M | $6M | $6M | |
| Stock-based Comp | $24M | $14M | $14M | $12M | $11M | $7M | $9M | $6M | $7M | $6M | $5M | $3M | |
| Deferred Tax | $37.0K | $-2M | $-1M | $-885.0K | $-6M | $816.0K | $-2M | $-6M | $-1M | $3M | $1M | $173.0K | |
| Amort. of Intangibles | $14M | $16M | $15M | $15M | $17M | $14M | $11M | $11M | $5M | $4M | $2M | $2M | |
| Other Non-cash | $-17M | $-1M | $13M | $-20M | $-17M | $611.0K | $-11M | $-5M | $-8M | $-8M | · | $-9M | |
| Operating Cash Flow | $40M | $22M | $19M | $-5M | $-3M | $12M | $16M | $10M | $11M | $20M | $11M | $8M | |
| CapEx | $39M | $11M | $10M | $11M | $13M | $7M | $8M | $6M | $7M | $6M | $3M | $4M | |
| Investing Cash Flow | $-42M | $-28M | $-502.0K | $-11M | $6M | $-73M | $-24M | $-7M | $-171M | $-79M | $-4M | · | |
| Debt Issued | $0 | $184M | $0 | $0 | · | · | · | · | · | · | · | · | |
| Net Debt Issued | $-210.0K | $-28M | $-3M | · | · | · | · | · | · | · | · | · | |
| Stock Issued | $13M | $6M | $4M | $3M | $4M | $2M | $5M | $4M | $3M | $2M | $2M | $3M | |
| Stock Repurchased | · | · | · | · | · | · | · | · | · | · | · | $6M | |
| Net Stock Activity | $13M | $6M | $4M | $3M | $4M | $2M | $5M | $4M | $3M | $2M | · | $-3M | |
| Dividends Paid | · | · | · | · | · | · | · | · | · | · | $3M | $3M | |
| Financing Cash Flow | $11M | $2M | $865.0K | $-2M | $-12M | $94M | $-1M | $-3M | $143M | $73M | $-3M | · | |
| Net Change in Cash | $11M | $-5M | $20M | $-16M | $-7M | $28M | $-8M | $1M | $-17M | $14M | $4M | $-4M | |
| Taxes Paid | $3M | · | · | · | · | · | · | · | · | · | $145.0K | $3M | |
| Free Cash Flow | $839.0K | $11M | $11M | $-14M | $-16M | $5M | $8M | $4M | $4M | $14M | · | $4M | |
| Levered FCF | · | · | $-25M | $-38M | $-33M | $-11M | $-8M | $-3M | $-925.8K | $12M | · | · |
Profitability 8
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 64.4% | 64.0% | 64.7% | 64.5% | 66.1% | 66.3% | 66.3% | 65.8% | 67.8% | 65.9% | · | 63.1% | |
| Operating Margin | 7.6% | 10.0% | 1.6% | 2.0% | 2.7% | 0.96% | 6.2% | 3.5% | 4.2% | 12.1% | · | 6.1% | |
| Net Margin | 2.2% | -3.4% | -8.7% | -6.1% | -5.0% | -6.6% | 0.62% | -1.1% | 1.9% | 6.0% | · | 5.1% | |
| Pretax Margin | 3.4% | -1.9% | -6.1% | -4.8% | -5.0% | -6.8% | 0.60% | -2.4% | 1.9% | 10.2% | · | 6.0% | |
| EBITDA Margin | 12.7% | 16.2% | 8.1% | 9.1% | 10.7% | 9.1% | 12.8% | 10.4% | 9.3% | 16.7% | · | 10.3% | |
| ROA | 1.2% | -1.7% | -4.0% | -2.5% | -1.9% | -2.4% | 0.29% | -0.49% | 0.82% | 4.3% | · | 4.2% | |
| ROE | 2.2% | -4.6% | -11.1% | -7.1% | -4.9% | -5.1% | 0.61% | -1.0% | 1.5% | 5.9% | · | 5.0% | |
| ROIC | 3.4% | 11.7% | 1.4% | 1.3% | 1.3% | 0.38% | 3.6% | 0.84% | 1.7% | 4.5% | · | 5.0% |
Liquidity & Solvency 5
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.5 | 4.3 | 4.9 | 5.0 | 5.5 | 3.9 | 4.1 | 5.2 | 4.2 | 4.9 | · | 5.1 | |
| Quick Ratio | 1.5 | 2.0 | 2.3 | 2.0 | 2.4 | 1.8 | 1.9 | 2.6 | 2.0 | 2.8 | · | 2.6 | |
| Debt / Equity | 0.5 | 1.1 | 1.1 | 1.1 | 1.0 | 0.9 | 0.8 | 0.8 | 0.8 | 0.3 | · | · | |
| LT Debt / Equity | 0.5 | 1.1 | 1.1 | 1.1 | 1.0 | 0.9 | 0.8 | 0.8 | 0.8 | 0.3 | · | · | |
| Interest Coverage | · | · | 0.2 | 0.3 | 0.5 | 0.1 | 1.1 | 0.6 | 1.6 | 7.3 | · | · |
Efficiency 3
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.5 | 0.5 | 0.4 | 0.4 | 0.4 | 0.5 | 0.5 | 0.4 | 0.7 | · | 0.8 | |
| Inventory Turnover | 1.8 | 1.7 | 1.6 | 1.5 | 1.4 | 1.4 | 1.9 | 1.9 | 1.7 | 3.0 | · | 4.7 | |
| Receivables Turnover | 5.2 | 5.1 | 5.3 | 5.5 | 6.0 | 5.1 | 5.5 | 5.6 | 5.0 | 7.0 | · | 7.4 |
Growth Rates 3
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 13.6% | 9.8% | 12.8% | 5.0% | 18.0% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 12.0% | 9.1% | 11.8% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 11.8% | · | · | · | · | · | · | · | · | · | · | · |
Valuation (TTM) 17
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $441M | $389M | $354M | $314M | $299M | $253M | $276M | $263M | $190M | $180M | $146M | $145M | |
| Net Income TTM | $10M | $-13M | $-31M | $-19M | $-15M | $-17M | $2M | $-3M | $4M | $11M | $4M | $7M | |
| Market Cap | $2.25B | $1.24B | $761M | $507M | $842M | $954M | $1.06B | $1.09B | $720M | $656M | · | $331M | |
| Enterprise Value | $2.40B | $1.50B | $1.01B | $776M | $1.10B | $1.18B | $1.24B | $1.27B | $899M | $670M | · | · | |
| P/E | 217.2 | -89.3 | -23.8 | -25.2 | -53.6 | -53.7 | 541.8 | -354.8 | 174.1 | 59.8 | 77.0 | 45.3 | |
| P/S | 5.1 | 3.2 | 2.2 | 1.6 | 2.8 | 3.8 | 3.8 | 4.2 | 3.8 | 3.6 | · | 2.3 | |
| P/B | 5.0 | 4.5 | 2.7 | 1.8 | 2.8 | 2.9 | 3.7 | 4.0 | 2.6 | 3.1 | · | 2.2 | |
| P / Tangible Book | 31.9 | · | · | · | · | · | · | · | · | · | · | · | |
| P / Cash Flow | 56.4 | 55.8 | 40.4 | -98.4 | -325.9 | 77.1 | 66.8 | 110.5 | 66.7 | 33.2 | · | 40.8 | |
| P / FCF | 2681.7 | 112.4 | 66.8 | -35.8 | -53.7 | 189.2 | 136.3 | 266.6 | 172.7 | 48.5 | · | 87.0 | |
| EV / EBITDA | 42.7 | 23.8 | 35.0 | 27.1 | 34.2 | 51.1 | 35.0 | 46.2 | 50.8 | 22.2 | · | · | |
| EV / FCF | 2860.7 | 136.0 | 88.6 | -54.7 | -70.0 | 234.9 | 159.8 | 309.4 | 215.6 | 49.6 | · | · | |
| EV / Revenue | 5.4 | 3.9 | 2.9 | 2.5 | 3.7 | 4.7 | 4.5 | 4.8 | 4.7 | 3.7 | · | · | |
| Dividend Yield | · | · | · | · | · | · | · | · | · | · | · | 0.99% | |
| Earnings Yield | 0.46% | -1.1% | -4.2% | -4.0% | -1.9% | -1.9% | 0.18% | -0.28% | 0.57% | 1.7% | 1.3% | 2.2% | |
| Payout Ratio | · | · | · | · | · | · | · | · | · | · | · | 45.0% | |
| Annual Payout | · | · | · | · | · | · | · | · | · | · | $3M | $3M |
Income Statement 18
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $126M | $116M | $116M | $113M | $113M | $99M | $97M | $96M | $98M | $97M | $94M | $88M | $89M | $83M | $79M | $77M | |
| Cost of Revenue | $45M | $41M | $43M | $39M | $40M | $35M | $36M | $35M | $35M | $34M | $33M | $32M | $31M | $30M | $29M | $28M | |
| Gross Profit | $81M | $75M | $73M | $74M | $73M | $64M | $62M | $61M | $63M | $63M | $61M | $56M | $58M | $54M | $51M | $49M | |
| R&D Expense | $9M | $9M | $9M | $8M | $7M | $7M | $7M | $7M | $7M | $7M | $8M | $6M | $7M | $7M | $8M | $12M | |
| SG&A Expense | $80M | $61M | $57M | $57M | $58M | $55M | $51M | $50M | $49M | $31M | $50M | $51M | $57M | $50M | $38M | $41M | |
| Operating Expenses | $89M | $70M | $66M | $65M | $65M | $61M | $59M | $57M | $57M | $38M | $58M | $58M | $65M | $58M | $47M | $53M | |
| Operating Income | $-8M | $6M | $11M | $13M | $8M | $2M | $3M | $4M | $7M | $25M | $3M | $-1M | $8M | $-4M | $4M | $-4M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $8M | · | $7M | $6M | $6M | · | $5M | |
| Interest Income | $367.0K | $205.0K | $311.0K | $240.0K | $68.0K | $144.0K | $374.0K | $366.0K | $353.0K | $374.0K | $398.0K | $339.0K | $265.0K | $75.0K | $61.0K | $40.0K | |
| Other Non-op | $4M | $-286.0K | $1M | $399.0K | $5M | $3M | $-10M | $2M | $-983.0K | $-1M | $2M | $-2M | $-4M | $963.0K | $4M | $-4M | |
| Pretax Income | $-12M | $339.0K | $7M | $7M | $3M | $-2M | $-17M | $-1M | $-2M | $13M | $-591.0K | $-9M | $-3M | $-9M | $3M | $-13M | |
| Income Tax | $2M | $-1M | $4M | $554.0K | $2M | $-2M | $-119.0K | $1M | $-306.0K | $5M | $3M | $382.0K | $725.0K | $5M | $1M | $1M | |
| Net Income | $-14M | $1M | $2M | $7M | $1M | $-505.0K | $-16M | $-2M | $-2M | $8M | $-4M | $-10M | $-3M | $-14M | $2M | $-14M | |
| EPS (Basic) | $-0.28 | $0.03 | $0.06 | $0.14 | $0.03 | $-0.01 | $-0.40 | $-0.05 | $-0.05 | $0.18 | $-0.10 | $-0.24 | $-0.08 | $-0.33 | $0.05 | $-0.34 | |
| EPS (Diluted) | $-0.28 | $0.03 | $0.06 | $0.13 | $0.03 | $-0.01 | $-0.40 | $-0.05 | $-0.05 | $0.18 | $-0.10 | $-0.24 | $-0.08 | $-0.33 | $0.05 | $-0.34 | |
| Shares (Basic) | 48,541,000 | 48,074,000 | -88,426,000 | 47,233,000 | 44,296,000 | 42,232,000 | -83,141,000 | 41,844,000 | 41,683,000 | 41,290,000 | -81,325,000 | 40,881,000 | 40,755,000 | 40,432,000 | -79,964,000 | 40,115,000 | |
| Shares (Diluted) | 48,541,000 | 49,731,000 | -89,223,000 | 48,775,000 | 45,378,000 | 42,232,000 | -89,737,000 | 41,844,000 | 41,683,000 | 47,886,000 | -81,325,000 | 40,881,000 | 40,755,000 | 40,432,000 | -79,964,000 | 40,115,000 | |
| EBITDA | $-8M | $12M | · | $13M | $8M | $8M | · | $4M | $7M | $31M | · | $-1M | $8M | $2M | · | $-4M |
Balance Sheet 26
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $77M | $56M | $65M | $73M | $53M | $38M | $53M | $56M | $55M | $51M | · | $53M | $49M | $31M | · | $38M | |
| Receivables | $98M | $92M | $90M | $88M | $91M | $88M | $79M | $76M | $74M | $74M | · | $64M | $65M | $63M | · | $57M | |
| Inventory | $103M | $98M | $92M | $91M | $87M | $82M | $80M | $84M | $81M | $82M | · | $79M | $78M | $76M | · | $73M | |
| Prepaid Expense | $27M | $45M | $43M | $22M | $25M | $20M | $19M | $19M | $20M | $17M | · | $17M | $19M | $20M | · | $17M | |
| Current Assets | $371M | $358M | $358M | $337M | $319M | $287M | $290M | $288M | $285M | $277M | · | $267M | $264M | $241M | · | $238M | |
| PP&E (Net) | $74M | $68M | $65M | $41M | $40M | $38M | $36M | $38M | $37M | $38M | · | $37M | $38M | $39M | · | $36M | |
| Goodwill | $350M | $252M | $254M | $254M | $254M | $245M | $241M | $249M | $244M | $245M | $247M | $243M | $246M | $246M | $244M | $235M | |
| Intangibles | $149M | $120M | $124M | $126M | $129M | $128M | $128M | $135M | $135M | $138M | · | $143M | $147M | $150M | · | $148M | |
| Other Non-current Assets | $15M | $16M | $15M | $29M | $27M | $25M | $24M | $21M | $14M | $13M | · | $8M | $8M | $8M | · | $7M | |
| Total Assets | $1.07B | $883M | $885M | $858M | $838M | $791M | $789M | $803M | $790M | $784M | · | $775M | $778M | $757M | · | $743M | |
| Accounts Payable | $21M | $18M | $16M | $16M | $19M | $12M | $18M | $11M | $12M | $10M | · | $11M | $10M | $9M | · | $11M | |
| Accrued Liabilities | $16M | $17M | $16M | $12M | $11M | $12M | $12M | $16M | $16M | $16M | · | $10M | $10M | $10M | · | $10M | |
| Current Liabilities | $107M | $93M | $102M | $86M | $67M | $52M | $67M | $153M | $51M | $46M | · | $55M | $56M | $44M | · | $46M | |
| Capital Leases | $36M | $34M | $34M | $38M | $39M | $39M | $40M | $41M | $42M | $43M | · | $43M | $40M | $41M | · | $41M | |
| Deferred Tax | $26M | $28M | $24M | $22M | $23M | $22M | $20M | $19M | $22M | $22M | · | $20M | $19M | $24M | · | $34M | |
| Other Non-current Liabilities | $9M | $9M | $9M | $9M | $9M | $8M | $8M | $8M | $8M | $8M | · | $8M | $7M | $7M | · | $7M | |
| Total Liabilities | $626M | $433M | $437M | $419M | $418M | $497M | $513M | $498M | $494M | $489M | · | $503M | $495M | $477M | · | $488M | |
| Long-term Debt | $363M | $215M | $215M | $215M | $216M | $315M | $314M | $314M | $314M | $313M | · | $307M | $308M | $308M | · | $308M | |
| Total Debt | $363M | $215M | · | $215M | $216M | $315M | · | $314M | $314M | $313M | · | $307M | $308M | $308M | · | $308M | |
| Common Stock | $502.0K | $500.0K | $493.0K | $488.0K | $486.0K | $442.0K | $434.0K | $434.0K | $433.0K | $432.0K | · | $425.0K | $424.0K | $424.0K | · | $418.0K | |
| Retained Earnings | $-64M | $-50M | $-51M | $-54M | $-60M | $-62M | $-61M | $-45M | $-42M | $-40M | · | $-44M | $-34M | $-31M | · | $-19M | |
| Treasury Stock | $15M | $15M | $15M | $15M | $15M | $15M | $15M | $15M | $15M | $15M | · | $15M | $15M | $15M | · | $15M | |
| AOCI | $-12M | $-12M | $-3M | $-2M | $-3M | $-19M | $-25M | $-10M | $-16M | $-14M | · | $-21M | $-16M | $-18M | · | $-45M | |
| Stockholders' Equity | $446M | $450M | $448M | $439M | $420M | $294M | $276M | $305M | $295M | $295M | $282M | $272M | $283M | $280M | $284M | $255M | |
| Liabilities + Equity | $1.07B | $883M | $885M | $858M | $838M | $791M | $789M | $803M | $790M | $784M | · | $775M | $778M | $757M | · | $743M | |
| Shares Outstanding | 50,179,000 | 49,983,000 | 49,330,000 | 48,862,000 | 48,592,000 | 44,190,000 | 43,432,000 | 43,392,000 | · | · | 42,569,000 | 42,537,000 | 42,443,000 | 42,366,000 | 41,830,000 | 41,816,000 |
Cash Flow 16
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $7M | $6M | $6M | $6M | $6M | $5M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | $5M | $6M | |
| Stock-based Comp | $8M | $8M | $4M | $6M | $6M | $8M | $3M | $4M | $4M | $3M | $4M | $3M | $4M | $3M | $3M | $3M | |
| Deferred Tax | · | · | · | · | · | · | $3M | · | · | · | $6M | · | · | · | · | · | |
| Amort. of Intangibles | $4M | $4M | $3M | $3M | $3M | $3M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | |
| Other Non-cash | · | $-15M | · | · | · | $-30M | · | · | · | $-22M | · | · | · | $-2M | · | · | |
| Operating Cash Flow | $-1M | $1M | $20M | $22M | $15M | $-17M | $10M | $11M | $6M | $-5M | $11M | $7M | $7M | $-6M | $-217.0K | $4M | |
| CapEx | $11M | $8M | $28M | $5M | $3M | $4M | $1M | $4M | $3M | $4M | $3M | $3M | $3M | $3M | $4M | $3M | |
| Investing Cash Flow | $-129M | $-11M | $-31M | $-5M | $-3M | $-4M | $-11M | $-11M | $-3M | $-4M | $-3M | $-2M | $7M | $-3M | $-3M | $-3M | |
| Debt Issued | · | · | $0 | $0 | $0 | $0 | $-6M | $160M | $160M | $190M | $0 | $0 | $0 | $0 | · | · | |
| Net Debt Issued | · | $0 | · | · | · | $-66.0K | · | · | · | $-182M | · | · | · | · | · | · | |
| Stock Issued | $1M | $1M | $3M | $5M | $278.0K | $4M | $443.0K | $2M | $59.0K | $4M | $488.0K | $886.0K | $0 | $3M | $24.0K | $1M | |
| Net Stock Activity | · | $1M | · | · | · | $4M | · | · | · | $4M | · | · | · | $3M | · | · | |
| Financing Cash Flow | $152M | $463.0K | $2M | $2M | $3M | $4M | $174.0K | $1M | $-181.0K | $737.0K | $-2M | $-909.0K | $2M | $1M | $-859.0K | $252.0K | |
| Net Change in Cash | $22M | $-9M | $-9M | $20M | $16M | $-16M | $-3M | $1M | $4M | $-8M | $5M | $5M | $18M | $-9M | $2M | $-3M | |
| Free Cash Flow | · | $-7M | · | · | · | $-21M | · | · | · | $-9M | · | · | · | $-8M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-14M | · | · | · | $-18M | · | · |
Profitability 8
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 64.0% | 64.8% | · | 65.6% | 64.7% | 64.2% | · | 63.7% | 64.6% | 64.6% | · | 64.0% | 65.1% | 64.5% | · | 63.4% | |
| Operating Margin | -6.7% | 5.0% | · | 11.1% | 7.4% | 2.2% | · | 4.6% | 6.6% | 26.0% | · | -1.4% | 8.6% | -4.6% | · | -5.3% | |
| Net Margin | -10.7% | 1.2% | · | 5.7% | 1.2% | -0.51% | · | -2.4% | -2.2% | 7.7% | · | -11.2% | -3.8% | -16.3% | · | -17.8% | |
| Pretax Margin | -9.3% | 0.29% | · | 6.2% | 3.1% | -2.3% | · | -1.3% | -2.5% | 13.1% | · | -10.7% | -3.0% | -10.7% | · | -16.3% | |
| EBITDA Margin | -6.7% | 10.4% | · | 11.1% | 7.4% | 7.7% | · | 4.6% | 6.6% | 32.0% | · | -1.4% | 8.6% | 2.2% | · | -5.3% | |
| ROA | -1.4% | 0.17% | · | 0.78% | 0.17% | -0.06% | · | -0.29% | -0.27% | 0.98% | · | -1.3% | -0.44% | -1.8% | · | -1.8% | |
| ROE | -3.1% | 0.38% | · | 1.8% | 0.38% | -0.17% | · | -0.79% | -0.73% | 2.6% | · | -3.7% | -1.2% | -4.7% | · | -4.8% | |
| ROIC | -1.2% | 3.6% | · | 1.8% | 0.51% | 0.08% | · | 1.3% | 0.93% | 2.5% | · | -0.22% | 1.7% | -1.0% | · | -0.80% |
Liquidity & Solvency 5
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.5 | 3.9 | · | 3.9 | 4.8 | 5.5 | · | 1.9 | 5.6 | 6.0 | · | 4.9 | 4.7 | 5.5 | · | 5.2 | |
| Quick Ratio | 1.6 | 1.6 | · | 1.9 | 2.2 | 2.4 | · | 0.9 | 2.5 | 2.7 | · | 2.1 | 2.0 | 2.1 | · | 2.1 | |
| Debt / Equity | 0.8 | 0.5 | · | 0.5 | 0.5 | 1.1 | · | 1.0 | 1.1 | 1.1 | · | 1.1 | 1.1 | 1.1 | · | 1.2 | |
| LT Debt / Equity | 0.8 | 0.5 | · | 0.5 | 0.5 | 1.1 | · | 0.7 | 1.1 | 1.1 | · | 1.1 | 1.1 | 1.1 | · | 1.2 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 3.2 | · | -0.2 | 1.2 | -0.6 | · | -0.9 |
Efficiency 3
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.5 | 0.5 | · | 0.4 | 0.5 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | |
| Receivables Turnover | 1.3 | 1.3 | · | 1.4 | 1.4 | 1.2 | · | 1.4 | 1.4 | 1.4 | · | 1.4 | 1.5 | 1.4 | · | 1.4 |
Valuation (TTM) 14
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $468M | $442M | · | $421M | $406M | $390M | · | $379M | $373M | $358M | · | $337M | $330M | $318M | · | $307M | |
| Net Income TTM | $-4M | $9M | · | $5M | $-4M | $3M | · | $-7M | $-8M | $-19M | · | $-40M | $-35M | $-35M | · | $-11M | |
| Market Cap | $1.13B | $1.83B | · | $2.07B | $1.51B | $1.09B | · | $1.16B | · | · | · | $645M | $730M | $555M | · | $579M | |
| Enterprise Value | $1.41B | $1.99B | · | $2.21B | $1.67B | $1.36B | · | $1.41B | · | · | · | $899M | $988M | $832M | · | $849M | |
| P/E | -249.7 | 203.4 | · | 423.4 | -388.8 | 351.1 | · | -166.4 | -135.0 | -45.0 | · | -15.3 | -20.0 | -15.2 | · | -51.3 | |
| P/S | 2.4 | 4.1 | · | 4.9 | 3.7 | 2.8 | · | 3.0 | · | · | · | 1.9 | 2.2 | 1.7 | · | 1.9 | |
| P/B | 2.5 | 4.1 | · | 4.7 | 3.6 | 3.7 | · | 3.8 | · | · | · | 2.4 | 2.6 | 2.0 | · | 2.3 | |
| P / Tangible Book | · | 23.2 | · | 35.5 | 41.0 | · | · | · | · | · | · | · | · | · | · | · | |
| P / Cash Flow | · | 1586.1 | · | · | · | -64.1 | · | · | · | · | · | · | · | -90.2 | · | · | |
| P / FCF | · | -267.2 | · | · | · | -52.8 | · | · | · | · | · | · | · | -66.1 | · | · | |
| EV / EBITDA | -169.0 | 164.1 | · | 176.3 | 199.6 | 179.6 | · | 322.1 | · | · | · | -722.5 | 128.8 | 444.3 | · | -206.9 | |
| EV / FCF | · | -290.5 | · | · | · | -66.2 | · | · | · | · | · | · | · | -99.2 | · | · | |
| EV / Revenue | 3.0 | 4.5 | · | 5.2 | 4.1 | 3.5 | · | 3.7 | · | · | · | 2.7 | 3.0 | 2.6 | · | 2.8 | |
| Earnings Yield | -0.40% | 0.49% | · | 0.24% | -0.26% | 0.28% | · | -0.60% | -0.74% | -2.2% | · | -6.5% | -5.0% | -6.6% | · | -1.9% |
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
Income Statement
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Revenue | $441M | $389M | $354M | $314M | $299M |
| Gross Margin % | 64.4% | 64.0% | 64.7% | 64.5% | 66.1% |
| Operating Margin % | 7.6% | 10.0% | 1.6% | 2.0% | 2.7% |
| Net Income | $10M | $-13M | $-31M | $-19M | $-15M |
| Diluted EPS | $0.21 | $-0.32 | $-0.75 | $-0.48 | $-0.38 |
Balance Sheet
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Debt / Equity | 0.5 | 1.1 | 1.1 | 1.1 | 1.0 |
| Current Ratio | 3.5 | 4.3 | 4.9 | 5.0 | 5.5 |
| Quick Ratio | 1.5 | 2.0 | 2.3 | 2.0 | 2.4 |
Cash Flow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Free Cash Flow | $839.0K | $11M | $11M | $-14M | $-16M |
Latest News Recent headlines mentioning this company
My Metrics Your personal watchlist — selected rows from Full Fundamentals
📊
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Institutional owners (13F) 217 filers · $728.9M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 42 (+7 vs prior Q) | 64 (+28 vs prior Q) | 80 (-7 vs prior Q) | 47 (-16 vs prior Q) | +5.4M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $71,566,000 | 3,184,974 | 9.82% | Shares |
| Juniper Investment Company, LLC | $45,386,816 | 2,019,885 | 6.23% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $45,043,789 | 2,004,619 | 6.18% | Shares |
| FMR LLC | $41,871,497 | 1,863,440 | 5.74% | Shares |
| STATE STREET CORP | $41,750,406 | 1,858,051 | 5.73% | Shares |
| Ophir Asset Management Pty Ltd | $40,446,180 | 1,800,008 | 5.55% | Shares |
| PERCEPTIVE ADVISORS LLC | $39,036,906 | 1,737,290 | 5.36% | Shares |
| Conestoga Capital Advisors, LLC | $36,484,539 | 1,623,700 | 5.01% | Shares |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | $23,011,325 | 1,024,091 | 3.16% | Shares |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $22,205,281 | 988,219 | 3.05% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $21,427,261 | 953,365 | 2.94% | Shares |
| DIMENSIONAL FUND ADVISORS LP | $20,062,856 | 892,873 | 2.75% | Shares |
| CITADEL ADVISORS LLC | $17,701,821 | 787,798 | 2.43% | Shares |
| YARGER WEALTH STRATEGIES, LLC | $15,278,432 | 634,223 | 2.10% | Shares |
| ROYCE & ASSOCIATES LP | $14,364,667 | 639,282 | 1.97% | Shares |
| WELLINGTON MANAGEMENT GROUP LLP | $11,702,264 | 520,795 | 1.61% | Shares |
| Qube Research & Technologies Ltd | $10,704,820 | 476,405 | 1.47% | Shares |
| FRED ALGER MANAGEMENT, LLC | $10,406,104 | 463,111 | 1.43% | Shares |
| TWO SIGMA ADVISERS, LP | $9,974,907 | 218,700 | 1.37% | Shares |
| D. E. Shaw & Co., Inc. | $9,846,714 | 438,216 | 1.35% | Shares |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $9,183,579 | 408,704 | 1.26% | Shares |
| Toroso Investments, LLC | $9,018,146 | 197,723 | 1.24% | Shares |
| Soleus Capital Management, L.P. | $8,718,360 | 388,000 | 1.20% | Shares |
| TWO SIGMA INVESTMENTS, LP | $8,702,159 | 387,279 | 1.19% | Shares |
| Balyasny Asset Management L.P. | $8,584,686 | 382,051 | 1.18% | Shares |
| GOLDMAN SACHS GROUP INC | $7,733,095 | 344,152 | 1.06% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $6,978,103 | 310,552 | 0.96% | Shares |
| KENNEDY CAPITAL MANAGEMENT LLC | $6,611,371 | 294,231 | 0.91% | Shares |
| UBS Group AG | $6,026,544 | 268,204 | 0.83% | Shares |
| WASATCH ADVISORS LP | $5,726,929 | 156,388 | 0.79% | Shares |
| BRIDGER MANAGEMENT, LLC | $4,855,373 | 132,588 | 0.67% | Shares |
| Quantinno Capital Management LP | $4,497,191 | 200,142 | 0.62% | Shares |
| AMERIPRISE FINANCIAL INC | $4,347,068 | 193,461 | 0.60% | Shares |
| FIFTH THIRD BANCORP | $4,170,912 | 185,621 | 0.57% | Shares |
| ORBIMED ADVISORS LLC | $3,932,250 | 175,000 | 0.54% | Shares |
| Corient Private Wealth LP | $3,578,618 | 159,262 | 0.49% | Shares |
| Public Sector Pension Investment Board | $3,298,304 | 146,787 | 0.45% | Shares |
| Parkman Healthcare Partners LLC | $3,121,982 | 138,940 | 0.43% | Shares |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $2,879,149 | 128,133 | 0.40% | Shares |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | $2,857,263 | 127,159 | 0.39% | Shares |
| Summit Creek Advisors LLC | $2,704,354 | 120,354 | 0.37% | Shares |
| CONNORS INVESTOR SERVICES INC | $2,700,445 | 120,180 | 0.37% | Shares |
| BNP PARIBAS FINANCIAL MARKETS | $2,693,816 | 119,885 | 0.37% | Shares |
| Bank of New York Mellon Corp | $2,522,415 | 112,257 | 0.35% | Shares |
| RHUMBLINE ADVISERS | $2,373,280 | 105,621 | 0.33% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $2,303,872 | 102,531 | 0.32% | Shares |
| XTX Topco Ltd | $2,173,905 | 96,747 | 0.30% | Shares |
| Swiss National Bank | $1,914,444 | 85,200 | 0.26% | Shares |
| BANK OF AMERICA CORP /DE/ | $1,912,535 | 85,115 | 0.26% | Shares |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $1,875,420 | 51,213 | 0.26% | Shares |
| LAZARD ASSET MANAGEMENT LLC | $1,875,301 | 83,458 | 0.26% | Shares |
| RENAISSANCE TECHNOLOGIES LLC | $1,524,073 | 67,827 | 0.21% | Shares |
| ALLIANCEBERNSTEIN L.P. | $1,522,477 | 41,575 | 0.21% | Shares |
| Legal & General Group Plc | $1,468,954 | 65,374 | 0.20% | Shares |
| CITIGROUP INC | $1,425,856 | 63,456 | 0.20% | Shares |
| Squarepoint Ops LLC | $1,424,238 | 63,384 | 0.20% | Shares |
| Russell Investments Group, Ltd. | $1,303,125 | 57,994 | 0.18% | Shares |
| VICTORY CAPITAL MANAGEMENT INC | $1,193,157 | 53,100 | 0.16% | Shares |
| ENVESTNET ASSET MANAGEMENT INC | $1,117,972 | 49,754 | 0.15% | Shares |
| Sterling Capital Management LLC | $1,098,918 | 48,906 | 0.15% | Shares |
| Sio Capital Management, LLC | $1,089,368 | 48,481 | 0.15% | Shares |
| BOOTHBAY FUND MANAGEMENT, LLC | $1,010,521 | 44,972 | 0.14% | Shares |
| PRUDENTIAL FINANCIAL INC | $995,219 | 44,291 | 0.14% | Shares |
| WELLS FARGO & COMPANY/MN | $937,314 | 41,714 | 0.13% | Shares |
| VANGUARD GROUP INC | $898,699 | 19,704 | 0.12% | Shares |
| FIRST TRUST ADVISORS LP | $857,657 | 38,169 | 0.12% | Shares |
| BlackRock, Inc. | $789,461 | 35,134 | 0.11% | Shares |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $738,274 | 32,856 | 0.10% | Shares |
| Verition Fund Management LLC | $729,399 | 32,461 | 0.10% | Shares |
| Aquatic Capital Management LLC | $712,771 | 31,721 | 0.10% | Shares |
| Jain Global LLC | $680,908 | 30,303 | 0.09% | Shares |
| JONES FINANCIAL COMPANIES LLLP | $662,072 | 28,042 | 0.09% | Shares |
| Brevan Howard Capital Management LP | $652,461 | 29,037 | 0.09% | Shares |
| VANGUARD ASSET MANAGEMENT, Ltd | $634,193 | 28,224 | 0.09% | Shares |
| JANUS HENDERSON GROUP PLC | $623,335 | 17,038 | 0.09% | Shares |
| MetLife Investment Management, LLC | $601,050 | 26,749 | 0.08% | Shares |
| Y-Intercept (Hong Kong) Ltd | $600,735 | 26,735 | 0.08% | Shares |
| Mariner, LLC | $570,520 | 25,390 | 0.08% | Shares |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | $561,750 | 25,000 | 0.08% | Shares |
| Illinois Municipal Retirement Fund | $545,010 | 24,255 | 0.07% | Shares |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $516,855 | 23,002 | 0.07% | Shares |
| Walleye Capital LLC | $490,408 | 21,825 | 0.07% | Shares |
| Penn Capital Management Company, LLC | $489,689 | 21,793 | 0.07% | Shares |
| ALLSTATE CORP | $483,240 | 21,506 | 0.07% | Shares |
| EXCHANGE TRADED CONCEPTS, LLC | $476,948 | 21,226 | 0.07% | Shares |
| MORGAN STANLEY | $476,588 | 21,210 | 0.07% | Shares |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $473,241 | 21,061 | 0.06% | Shares |
| Louisiana State Employees Retirement System | $420,189 | 18,700 | 0.06% | Shares |
| Invesco Ltd. | $409,628 | 18,230 | 0.06% | Shares |
| DARK FOREST CAPITAL MANAGEMENT LP | $402,123 | 17,896 | 0.06% | Shares |
| Vanguard Global Advisers, LLC | $371,384 | 16,528 | 0.05% | Shares |
| Freestone Grove Partners LP | $328,219 | 14,607 | 0.05% | Shares |
| NEW YORK STATE COMMON RETIREMENT FUND | $324,287 | 14,432 | 0.04% | Shares |
| JOHNSON INVESTMENT COUNSEL INC | $307,008 | 13,663 | 0.04% | Shares |
| Police & Firemen's Retirement System of New Jersey | $303,053 | 13,487 | 0.04% | Shares |
| DIKER MANAGEMENT LLC | $303,000 | 13,500 | 0.04% | Shares |
| OPPENHEIMER ASSET MANAGEMENT INC. | $284,672 | 12,669 | 0.04% | Shares |
| GUGGENHEIM CAPITAL LLC | $283,302 | 12,608 | 0.04% | Shares |
| ELEVATION POINT WEALTH PARTNERS, LLC | $263,303 | 11,718 | 0.04% | Shares |
| Vestmark Advisory Solutions, Inc. | $263,303 | 11,718 | 0.04% | Shares |
Company insiders 49 insiders · 27 officers · 15 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| James P Mackin | President & CEO | March 6, 2025 M | 865,283 | 0 | 0 | $0 |
| David Ashley Lee | Executive VP, COO & CFO | March 2, 2023 S | 347,217 | 0 | 0 | $0 |
| Marshall S. Stanton | SVP, Clinical & MD Affair | June 17, 2025 S | 64,200 | 0 | 0 | $0 |
| John E Davis | Chief Commercial Officer | March 11, 2025 M | 208,778 | 0 | 0 | $0 |
| Amy Horton | VP, Chief Accounting Officer | March 6, 2025 S | 146,651 | 0 | 0 | $0 |
| Matthew A Getz | VP, Human Resources | Aug. 16, 2024 S | 34,116 | 0 | 0 | $0 |
| Florian Tyrs | VP, Global Operations | Feb. 27, 2024 S | 21,558 | 0 | 0 | $0 |
| Rochelle L. Maney | VP, Quality | Feb. 26, 2024 S | 44,518 | 0 | 0 | $0 |
| Robert C Thomson | VP Research & Development | Feb. 23, 2024 A | 13,291 | 0 | 0 | $0 |
| Dennis B Maier | SVP, Operations | June 6, 2023 S | 34,724 | 0 | 0 | $0 |
| Franz Peter Barthold | VP, Research & Development | Nov. 8, 2022 A | 32,516 | 0 | 0 | $0 |
| Scott B Capps | VP, Clinical Research | March 12, 2021 F | 153,203 | 0 | 0 | $0 |
| James M Mcdermid | SVP, CHRO | March 14, 2019 F | 30,806 | 0 | 0 | $0 |
| Sherry M Saurini | VP, Quality | March 14, 2019 F | 25,084 | 0 | 0 | $0 |
| William Robert Matthews | Senior VP, Operations, Quality | March 5, 2018 F | 39,883 | 0 | 0 | $0 |
| David C Gale | VP, Research & Development | Nov. 16, 2017 M | 77,135 | 0 | 0 | $0 |
| Steven G Anderson | Former Executive Chairman | April 9, 2015 F | 1,271,846 | 0 | 0 | $0 |
| Bruce G. Anderson | VP, US Sales &Global Marketing | March 7, 2015 F | 42,106 | 0 | 0 | $0 |
| FRONK DAVID | VP, Regulatory Affairs | March 7, 2015 F | 110,559 | 0 | 0 | $0 |
| David P. Lang | VP, Int'l Sales & Marketing | Feb. 26, 2015 A | 73,441 | 0 | 0 | $0 |
| Jeffrey W Burris | Vice President & Gen. Counsel | Aug. 15, 2014 M | 95,221 | 0 | 0 | $0 |
| Gerald B Seery | Sr. VP, Sales and Marketing | Nov. 30, 2012 S | 71,999 | 0 | 0 | $0 |
| Albert E Heacox | Sr. VP Research and Devl | Dec. 31, 2011 F | 110,144 | 0 | 0 | $0 |
| Philip A Theodore | VP, General Counsel | Sept. 4, 2007 A | 23,100 | 0 | 0 | $0 |
| Sidney B Ashmore | Vice President of Marketing | Jan. 18, 2006 M | 42,728 | 0 | 0 | $0 |
| Kirby S Black | Sr. Vice President, R&D | Sept. 21, 2004 M | 55,131 | 0 | 0 | $0 |
| Vander James C Wyk | VP - Product Integrity | Sept. 14, 2004 M | 36,165 | 0 | 0 | $0 |
| Anthony B. Semedo | Director | June 2, 2026 J | 6,325 | 0 | 0 | $0 |
| Elizabeth A Hoff | Director | May 22, 2025 A | 31,389 | 0 | 0 | $0 |
| Marna P Borgstrom | Director | May 22, 2025 A | 49,088 | 0 | 0 | $0 |
| Jon W Salveson | Director | May 22, 2025 A | 129,840 | 0 | 0 | $0 |
| Jeffrey H Burbank | Director | May 22, 2025 A | 53,796 | 0 | 0 | $0 |
| Daniel J Bevevino | Director | May 22, 2025 A | 150,061 | 0 | 0 | $0 |
| Bullock James | Director | May 22, 2025 A | 68,647 | 0 | 0 | $0 |
| Thomas F Ackerman | Director | May 22, 2025 A | 149,896 | 0 | 0 | $0 |
| Harvey Morgan | Director | Aug. 30, 2021 G | 46,342 | 0 | 0 | $0 |
| Ronald D Mccall | Director | Aug. 25, 2021 S | 121,768 | 0 | 0 | $0 |
| Elkins C Ronald | Director | Sept. 5, 2018 S | 64,843 | 0 | 0 | $0 |
| James Benson | Director | Oct. 2, 2017 S | 54,086 | 0 | 0 | $0 |
| John M Cook | Director | June 9, 2009 M | 85,000 | 0 | 0 | $0 |
| LACY VIRGINIA C | Director | April 24, 2007 S | 255,280 | 0 | 0 | $0 |
| VAN DYNE BRUCE J MD | Director | Aug. 1, 2006 A | 12,800 | 0 | 0 | $0 |
| OSS CAPITAL MANAGEMENT | 10% owner | May 31, 2007 S | 1,918,000 | 0 | 0 | $0 |
| Lance A Berry | — | Aug. 14, 2026 S | 210,112 | 0 | 1 | $-20,413 |
| Andrew M Green | — | Aug. 14, 2026 S | 59,643 | 0 | 3 | $-928,248 |
| Jean F Holloway | — | Aug. 12, 2026 S | 184,118 | 0 | 1 | $-27,835 |
| Michael S Simpson | — | March 5, 2021 F | 33,698 | 0 | 0 | $0 |
| Thomas J Bogenschuetz | — | May 5, 2020 A | 23,451 | 0 | 0 | $0 |
| Thomas J Lynch | — | Nov. 2, 2004 A | 5,000 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
Activists & 5%+ owners 5 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Juniper Targeted Opportunity Fund, L.P., Juniper HF Investors II, LLC, Juniper Targeted Opportunities, L.P., Juniper Targeted Opportunity Investors, LLC, Juniper Multi-Strategy Fund, L.P., Juniper HF Investors, LLC, Juniper Investment Company, LLC, Alexis P. Michas, John A. Bartholdson ×2 filings | Aug. 12, 2025 | 4.00% | Amendment | — | SEC |
| CryoLife, Inc., CL Falcon, Inc. | May 11, 2011 | — | Initial filing | M&A / sale | SEC |
| Michael A. Roth and Brian J. Stark, as joint filers pursuant to Rule 13d-1(k) | July 10, 2007 | — | Initial filing | — | SEC |
| Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person | Dec. 2, 2005 | — | Initial filing | Passive investment | SEC |
| Undisclosed reporting person | March 18, 2005 | — | Initial filing | Passive investment | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF ownership Held by 53 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| SAWS · ETF Series Solutions | 2.95% | 5,817 NS | April 30, 2026 | N-PORT |
| HTEC · EXCHANGE TRADED CONCEPTS TRUST | 1.77% | 26,421 NS | April 30, 2026 | N-PORT |
| PSCH · Invesco Exchange-Traded Fund Trust … | 0.59% | 37,075 SH | Aug. 8, 2026 | Daily |
| RZG · Invesco Exchange-Traded Fund Trust | 0.44% | 22,725 SH | Aug. 8, 2026 | Daily |
| SIXL · EXCHANGE TRADED CONCEPTS TRUST | 0.25% | 21,547 NS | May 31, 2026 | N-PORT |
| ESSC · Strategy Shares | 0.24% | 1,691 NS | April 30, 2026 | N-PORT |
| XSMO · Invesco Exchange-Traded Fund Trust | 0.21% | 246,008 SH | Aug. 8, 2026 | Daily |
| IHI · iShares Trust | 0.16% | 202,161 SH | Aug. 8, 2026 | Daily |
| IJT · iShares Trust | 0.13% | 397,869 SH | Aug. 8, 2026 | Daily |
| FYC · First Trust Exchange-Traded AlphaDE… | 0.11% | 31,285 NS | April 30, 2026 | N-PORT |
| VIOG · VANGUARD ADMIRAL FUNDS | 0.10% | 50,848 SH | Aug. 8, 2026 | Daily |
| QVMS · Invesco Exchange-Traded Fund Trust … | 0.08% | 7,285 SH | Aug. 8, 2026 | Daily |
| IWO · iShares Trust | 0.08% | 419,028 SH | Aug. 8, 2026 | Daily |
| XJR · iShares Trust | 0.07% | 5,059 SH | Aug. 8, 2026 | Daily |
| IJR · iShares Trust | 0.06% | 2,606,468 SH | Aug. 8, 2026 | Daily |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.06% | 49,054 SH | Aug. 8, 2026 | Daily |
| VIOO · VANGUARD ADMIRAL FUNDS | 0.05% | 148,966 SH | Aug. 8, 2026 | Daily |
| RSSL · Global X Funds | 0.05% | 18,968 NS | April 30, 2026 | N-PORT |
| SAA · ProShares Trust | 0.04% | 505 NS | May 31, 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0.04% | 158,121 NS | April 30, 2026 | N-PORT |
| IWM · iShares Trust | 0.04% | 1,162,604 SH | Aug. 8, 2026 | Daily |
| ISCG · iShares Trust | 0.04% | 14,407 SH | Aug. 8, 2026 | Daily |
| RWJ · Invesco Exchange-Traded Fund Trust … | 0.04% | 28,917 SH | Aug. 8, 2026 | Daily |
| GSSC · Goldman Sachs ETF Trust | 0.03% | 14,525 NS | May 31, 2026 | N-PORT |
| EBIT · Harbor ETF Trust | 0.03% | 101 NS | April 30, 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.03% | 263,046 SH | Aug. 8, 2026 | Daily |
| SMDX · Tidal Trust III | 0.03% | 999 NS | April 30, 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.03% | 27,103 SH | Aug. 8, 2026 | Daily |
| ITWO · ProShares Trust | 0.02% | 2,057 NS | May 31, 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0.02% | 18,392 NS | April 30, 2026 | N-PORT |
| FAD · First Trust Exchange-Traded AlphaDE… | 0.02% | 2,917 NS | April 30, 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0.02% | 200,917 NS | May 31, 2026 | N-PORT |
| ISCB · iShares Trust | 0.02% | 2,111 SH | Aug. 8, 2026 | Daily |
| UWM · ProShares Trust | 0.01% | 1,609 NS | May 31, 2026 | N-PORT |
| URTY · ProShares Trust | 0.01% | 1,624 NS | May 31, 2026 | N-PORT |
| JSTC · Tidal Trust I | 0.01% | 1,526 NS | May 31, 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.01% | 495,296 SH | Aug. 8, 2026 | Daily |
| VHT · VANGUARD WORLD FUND | 0.01% | 127,662 SH | Aug. 8, 2026 | Daily |
| WSML · iShares Trust | 0.01% | 2,264 SH | Aug. 8, 2026 | Daily |
| DFAC · Dimensional ETF Trust | 0.01% | 107,410 NS | April 30, 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0.01% | 1,773 NS | May 31, 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.00% | 3,861 NS | April 30, 2026 | N-PORT |
| HDG · ProShares Trust | 0.00% | 41 NS | May 31, 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0.00% | 1,937 NS | April 30, 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0.00% | 8,873 NS | April 30, 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0.00% | 12,377 NS | April 30, 2026 | N-PORT |
| ITOT · iShares Trust | 0.00% | 61,883 SH | Aug. 8, 2026 | Daily |
| IWV · iShares Trust | 0.00% | 10,738 SH | Aug. 8, 2026 | Daily |
| SCHB · SCHWAB STRATEGIC TRUST | 0.00% | 25,635 NS | May 31, 2026 | N-PORT |
| TILT · FlexShares Trust | 0.00% | 636 NS | April 30, 2026 | N-PORT |